National Covid-19 Surveillance Physicians

Antibody COVID-19 Clinical Trial

— NAT-COV-SURV  

Official title:

National Covid-Surveillance Physicians

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04459312
• Other study ID #: 2020_2
• Status: Recruiting
• Start date: June 1, 2020
• Est. completion date: September 30, 2020

Study information

• Verified date: July 2020
• Source: Heinrich-Heine University, Duesseldorf
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 600
• Est. completion date: September 30, 2020
• Est. primary completion date: July 10, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Qualified as physician

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Antibody COVID-19

Intervention

Diagnostic Test:
• Antibody test (SARS-CoV2)
Antibody test

Locations

Country	Name	City	State
Germany	University Hospital Duesseldorf, Dept. of Anesthesiology	Duesseldorf

Sponsors (2)

Lead Sponsor	Collaborator
Heinrich-Heine University, Duesseldorf	Dr. Wetzchewald

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of antibodies against SARS-COV2		3 months